Last week we shared information on BreatheHero, WhereAbles and Kappa Diagnostics. This week you can find out more about another three teams:
NanoGene Biomedical Technologies (NGBTech) is a start-up commercial enterprise focusing on the development of biomedical devices and products for cancer diagnostics and anti-cancer drug screening applications.
Green Spot / Not The End is developing Proteina, a low fat, low sugar, high fibre and high protein food product. The product is produced naturally from apple by-products.
InSight Technologies is developing EyeLine, a product that provides rapid on-site detection of patients at risk of primary open angle glaucoma.
Stay tuned next week to learn more.
Last week, Alleasing CEO, Daniel Blizzard, spoke with mergermarket.com.au regarding Alleasing’s mergers and acquisition plans and the company’s exciting new ventures into aviation, energy and medical financing. Read on to find out where Alleasing is headed.Read full story
New Zealand wineries are taking over Australian sales in the USA for the first time ever, with nearly $50 million more in sales. Have Australian wine makers become too confident or are the New Zealanders doing something different?Read full story
Tell us a little about your business so we can help you find what you need.
If you’d prefer to speak to an expert you can call us on 1300 134 214.